Lirentelimab for severe and chronic forms of allergic conjunctivitis
Journal of Allergy and Clinical Immunology(2022)
摘要
Lirentelimab was well tolerated, improved severe AC and concomitant atopic symptoms, and reduced inflammatory mediators in patient tears.
更多查看译文
关键词
AK002,sialic acid–binding immunoglobulin-like lectin-8,perennial allergic conjunctivitis,atopic keratoconjunctivitis,vernal keratoconjunctivitis,allergic conjunctival diseases,ocular allergy
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要